Search research articles
Contact Us
Filters
Showing results (681-690 of 799) with videos related to
Page
of 80
Sort By:
AJNR. American Journal of Neuroradiology
|
January 9, 2025
Deep learning MRI models for the differential diagnosis of tumefactive demyelination versus <i>IDH</i>-wildtype glioblastoma
Gian Marco Conte, Mana Moassefi, Paul A Decker, et al.
Cancer Genetics
|
March 2, 2011
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
Robert B Jenkins, Margaret R Wrensch, Derek Johnson, et al.
Cancer Research
|
October 22, 2009
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality
Lara S Collier, David J Adams, Christopher S Hackett, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial
Edith A Perez, Monica M Reinholz, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
The Lancet. Oncology
|
December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Page
of 80
Search research articles
Search
Showing results (681-690 of 799) with videos related to
Sort By:
Page
of 80
AJNR. American Journal of Neuroradiology
|
January 9, 2025
Deep learning MRI models for the differential diagnosis of tumefactive demyelination versus <i>IDH</i>-wildtype glioblastoma
Gian Marco Conte, Mana Moassefi, Paul A Decker, et al.
Cancer Genetics
|
March 2, 2011
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
Robert B Jenkins, Margaret R Wrensch, Derek Johnson, et al.
Cancer Research
|
October 22, 2009
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality
Lara S Collier, David J Adams, Christopher S Hackett, et al.
Neuro-Oncology
|
February 13, 2010
A multigene predictor of outcome in glioblastoma
Howard Colman, Li Zhang, Erik P Sulman, et al.
BMC Medical Genomics
|
December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
Monica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Geno Guerra, George Wendt, Lucie McCoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial
Edith A Perez, Monica M Reinholz, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831
Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
The Lancet. Oncology
|
December 3, 2014
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
John R Prensner, Shuang Zhao, Nicholas Erho, et al.
Page
of 80